Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 04-2011 | 01-2011 | 10-2010 | 07-2010 | 04-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 0 | 3,670 | 2,190 | 3,280 |
| Receivables | 0 | 0 | 440 | 330 | 380 |
| Inventories | 0 | 0 | 870 | 750 | 490 |
| Other current assets | 0 | 0 | 90 | 4 | 180 |
| TOTAL | $0 | $0 | $5,070 | $3,420 | $4,330 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1,530 | N/A |
| Intangibles | 0 | 0 | 0 | 1,873 | 0 |
| Other Non-Current Assets | 1,920 | 1,920 | 1,860 | -3 | 1,890 |
| TOTAL | $1,920 | $1,920 | $1,860 | $3,400 | $1,890 |
| Total Assets | $0 | $0 | $7,560 | $5,990 | $7,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 910 | 530 | 450 | 320 | 450 |
| Accrued Expenses | 210 | 300 | 310 | 240 | 280 |
| Other current liabilities | 0 | 320 | 350 | 10 | 9 |
| TOTAL | $0 | $0 | $1,110 | $580 | $740 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 10 | N/A |
| TOTAL | $8 | $10 | $10 | $10 | $10 |
| Total Liabilities | $0 | $0 | $1,130 | $590 | $760 |
| Shareholders' Equity | |||||
| Common Shares | 370 | 44,590 | 44,470 | 41,670 | 41,200 |
| Retained earnings | 0 | 0 | -47,280 | -45,260 | -43,580 |
| Other shareholders' equity | -51,720 | -51,260 | 2,810 | 2,940 | 3,070 |
| TOTAL | $0 | $0 | $6,430 | $5,390 | $6,330 |
| Total Liabilities And Equity | $0 | $0 | $7,560 | $5,980 | $7,090 |